抗病毒研究發(fā)表關(guān)于有效控制動(dòng)物和人類(lèi)以及植物或低等生物中病毒感染的完整原創(chuàng)文章、簡(jiǎn)短的權(quán)威論文和綜述文章(每期一篇)。范圍包括：宿主對(duì)病毒感染的天然和獲得性耐藥機(jī)制，包括細(xì)胞特異性耐藥性、干擾素、病毒感染中的細(xì)胞和體液免疫、影響宿主耐藥的化療藥物；開(kāi)發(fā)針對(duì)病毒性疾病的新疫苗或新療法，包括疫苗株或疫苗制劑的病毒學(xué)特征、抗病毒免疫球蛋白的合成與鑒定、安全性和效率評(píng)估、田間試驗(yàn)；開(kāi)發(fā)新的抗病毒化療藥物，包括化學(xué)藥物、體外活性的作用機(jī)制、動(dòng)物模型系統(tǒng)的活性、臨床試驗(yàn)。

Antiviral Research publishes full-length original articles, short definitive papers and review articles (one per issue) pertaining to the effective control of virus infections in animals and man as well as in plants or lower organisms. Its scope encompasses: -the mechanism of natural and acquired host resistance against virus infections, including aspecific cellular resistance, interferons, cellular and humoral immunity in virus infections, chemotherapeutics which influence host resistance; -the development of new vaccines or novel forms of serotherapy against viral diseases, including virological characterization of vaccine strains or vaccine preparations; preparation and characterization of antiviral immunoglobulins; safety and efficiency assessment; field trials; -the development of new antiviral chemotherapeutics, including chemistry; in vitro activity; mechanism of action; activity in animal model systems; clinical trials.